Rs 500 Crore: Zydus Wellness’ Revenue Target For FY14
DSIJ Intelligence / 13 May 2013
The company reported growth of 26% in its topline for Q4FY13, as its net profit Came in at Rs 38.17 crore.
Zydus wellness, a subsidiary of Cadila Healthcare, came out with its Q4 earnings today (May 13, 2013). The consumer healthcare company has reported 26% growth in its topline to Rs 108 crore. The net profit came in better at Rs 38.17 crore, up by 60%.
For the fiscal, the company reported revenues of Rs 410 crore with a YoY growth of 19%. The net profit stood at Rs 97 crore, up by 43.5%. Following the results, the company has also announced a dividend of Rs 6 per share which gives a dividend yield of 1.2% at the CMP of Rs 497.05.
The quarter has seen its EBITDA margins sliding from 28.80% a year ago to 27.81% for the March 2013 quarter. On a QoQ basis, however, its margins have expanded by 177 basis points.
The company has set a target of Rs 500 crore for its revenues for FY14 which will be a 22% growth in the topline in the next fiscal. Considering its growth numbers, we would advise readers to enter the counter with a target price of Rs 585 which would give 17% returns on the CMP.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.